Corin Share Discussion Threads

[rhtshah2] 27/9/2006 08:42

Buy says The Independent, and hopefully IC and weekend press will have similar views.

[hkwang] 26/9/2006 10:15

maybr big downside... p/e>45.

[m.t.glass] 26/9/2006 08:23

Strong in the hip, weak at the knees..


STOCKWATCH Corin Group up, Bridgewell Securities lifts to 'overweight' after H1

LONDON (AFX) - Shares in Corin Group were firmer in opening deals after
Bridgewell Securities upgraded the group to 'overweight' from 'underweight'
after the group posted 'mixed' interim numbers but an increasingly confident
outlook in the US, dealers said.
At 8.06 am, shares in Corin Group were 1-1/2 pence firmer at 200 while the
FTSE Small Cap index added 0.80 points at 3,487.4.
Earlier today, the health care equipment group posted first half pretax
profit of 1.7 mln stg, compared to 2.0 mln in the last year, while noting it
expects to see 'significant impact' in 2007 from progress in the US and Japan.
The group also expects to get FDA approval for its hip resurfacing product
Cormet towards the end of the year.
Reacting to the numbers, Bridgewell Securities said the results were 'mixed' but a solid performance in the UK hip market was countered by a poor performance in the knees, and Germany's competitiveness outweighed by good progress in Japan.
However, the broker noted that the recent share price weakness does not take into account the 'inherent approvability' of the hip system in the US, as
comparable to Smith & Nephew's.

[e-mail]
ze/cml

[m.t.glass] 16/8/2006 14:43

Corin ceo Ian Paling (the shorter fella), picking up some local business award

[a0152232] 24/7/2006 13:32

As far as I can understand it is all one product. i.e.the hip replacement which has been sold in Europe for many years & is still awaiting a much delayed approval by the US regulator.
This approval, or lack of it, is I beleive the reason for the very lacklustre price.
Once this is granted, & bearing in mind this has been marketed & sold in Europe for several years sucessfully with few (if any) problems,
the stock should increase significantly.

[m.t.glass] 23/7/2006 12:06

Sounds to me like they are talking of 2 resurfacing products - their own marketed worldwide (ex USA?) and Corin (maybe) within the US and possibly in competition with each other wherever the Corin deal allows that. But I too find it ambiguous.

[kirkie001] 22/7/2006 15:01

So are they saying that they are going to have another hip product other than Corin's Cormet? Or are they just referring to Corin?

[m.t.glass] 21/7/2006 09:13

Stryker CEO: Selling Hip Resurfacing Product Outside U.S.

By Jon Kamp Of DOW JONES NEWSWIRES
Orthopedic products company Stryker Corp. (SYK) recently rolled out a new hip resurfacing product in international markets, President and Chief Executive Stephen P. MacMillan said Thursday.
This marks Kalamazoo, Mich.-based Stryker's "initial entry" into the market for hip resurfacing, which is a bone-preserving alternative to full hip replacements for some patients and is seen in the orthopedics industry as technology that could help expand hip product sales. The concept is fairly old, but is gaining renewed prominence amid new product offerings.
Notably, U.K.-based Smith & Nephew PLC (SNN) recently brought a hip replacement product to the U.S. market. Stryker could enter the U.S. in 2007 through its agreement to market a hip resurfacing technology made by the U.K.'s Corin Group PLC (CRG.LN), MacMillan said.
Speaking on a call with analysts following Stryker's second-quarter earnings release, MacMillan said the company is "quietly" working with a different partner on the international front, although he described the Stryker international resurfacing product as more "internal." He said the product was rolled out in the last few weeks.
"While sales will be limited initially, we expect this to breathe renewed life into our international hip business over the coming quarters," MacMillan said on the call.
Stryker reported after the closing bell Thursday second-quarter earnings of $213.9 million, or 52 cents a share, up from $177.8 million, or 43 cents a share, in the year-earlier period.
The company also reported revenue in the quarter of $1.33 billion, up 9% from a year earlier, and worldwide orthopedic implant sales of $771.1 million, up 6.6%.
Analysts surveyed by Thomson First Call on average projected earnings of 51 cents a share on sales of $1.34 billion.
-By Jon Kamp, Dow Jones Newswires; 312-750-4129; [e-mail]

[m.t.glass] 13/7/2006 13:55

..Among casualties, traders made for the exit in Corin Group, 17-1/2 pence lower at 235, after the orthopaedic devices manufacturer warned trading for the six months to June showed only moderate growth compared with the final half last year due to a shortfall in sales in the second quarter.

However, the company hopes that a new marketing and distribution agreement with Stryker Corporation for its Uniglide knee joint system will help boost US sales.

First-quarter results were in line with expectations, but second-quarter sales fell short, leading the board to expect sales and pretax profits for the first half of 2006 to show only moderate growth compared to the second half of 2005.

---------------------------------------------------------------------


0729 GMT [Dow Jones] Bridgewell keeps Corin (CRG.LN) at underweight following a "mixed" trading update. Says near-term view is that sector has major issues and that "significant consolidation is unlikely to happen." Notes a poor performance in 2Q, with the main problems continuing in the UK healthcare equipment and services market. Shares trade -6.1% at 230p. (JEM)

[jimjamjob] 07/7/2006 12:23

Maybe six pounds when Stryker show support, include hip resurfacing product on their website and start selling the stuff.

[furno9] 16/5/2006 21:59

SIX POUNDS WITHIN SIX MONTHS

[furno9] 11/5/2006 17:01

1st order recieved in oct05 sencond order has already been placed so with such confidence between both corin and symmetry makes the FDA approval appear to be something of a formality (the deal has already been done no news until the creases have been ironed out though)

[foolamince] 11/5/2006 10:22

furno9
Exactly what product could symmetry market in the US to strengthen the bottom line?

I expect we will here lots of rumours in the coming of weeks as nervous holders ramp the share to allow their exit.

CRG is now a one trick pony, the future depends on FDA approval for Cormet, if approval doesn't come then it is hard to see what the attraction it has as an investment and the price must head downwards. Gearing up for a major product distribution, whilst delays continue, can only severly dent cashflow and poorly utilise company resources. We are now in quarter 2 and still nothing on cormet, meanwhile the birmingham hip is establishing itself in the US market.

If approval comes then we should expect to see a re-rating possibly even 400p without approval and more delays this is very overvalued

[curious] 11/5/2006 09:26

furno9
you mentioned a US marketing deal. Is your comment based on hard information or is it a hope?
Please clarify. thanks in advance.

[furno9] 08/5/2006 21:03

now is the time to buy good news will be annouced in the near future regarding U.S marketing deal with symmetry medical WILL KICK START A SERIOUS share price RISE

[m.t.glass] 11/3/2006 01:19

Ian - EMA exponential moving average (as opposed to SMA, simple moving average)
See

Can't remember why I opted for ema rather than ma on this thread. I don't usually.

As for it bouncing - I dunno. Nothing about it tempts me to buy at present.

[ianmckean] 11/3/2006 00:53

What does the "E" stand for in EMA?

Are we going to see a bounce now the graph has hit the 50 day EMA?

[a0152232] 21/12/2005 16:03

Have held these & sold on the decline.I believe they are overvalued at the moment but if FDA approval is forthcoming (& all the indications are that it will be) in the New Year these could soar. I would suggest a £6.00 target. If it falls to £2.50 it must be a bargain.

[m.t.glass] 12/12/2005 23:59

Mick - no, I have no position lately in this one. But having authored the thread I pop in now and then to see whether it is soaring (so I can claim credit for featuring it) or sinking (so I can tiptoe silently away and hope nobody notices, and maybe even contemplate a short).

[mickconn11] 12/12/2005 22:15

Staying short but reluctant to add due to recent BSX and GDT news.

Market cap is so small anyone of the big players can come in and buy it at a serious premium.

I'm considering adding GSL's to existing shorts as it's easier to sell other stuff at the moment and Corin has become a distraction.

Smith and Nephew is also super strong at the moment and it's easier to sell short tobacco and alcohol and other 'defensives'.

mtg... are you still playing.?

I'll look at the sector again if avian flu kicks in because these companies will lose alot of their customers. Mind you if the chickens come home to roost and bring their germs it could help this pension deficit problem the market is ignoring.

Doesn't affect me though. ... I'm 93 and fit as a fiddle.

[pcok] 11/12/2005 19:29

pw means its not looking so tempting. I hoped the fda approval followed by quick take over scenario was viable. It may still be but downside now exposed and a punt for the brave.

All the best to all holders. I am still watching and will rebuy if the worm turns as this market will grow and the big fellas need product.

[m.t.glass] 07/12/2005 12:52

Bloomberg version of today's pw:

Corin Group Plc (CRG LN), a maker of artificial knees and hips, fell 17.5 pence, or 5.3 percent, to 310. The company said this year's pretax profit will miss analysts' estimates because of a ``sharp and unexpected'' sales decline in the U.S. and Germany during the last four months.

(Last pw was August 11)

[mickconn11] 10/11/2005 20:45

325 tonight. Where next. ???

Anyone got a view on what this company is worth. ?

If they get the go ahead from the FDA or takeover rumours resurface it could fly. At the moment it just goes down and down and down.

Any thoughts. ( and brokers,analysts and rampers are welcome)... just dont forget to use a dodgy name..

[mickconn11] 31/10/2005 19:49

pcok. Why back in. ???

It's expensive.